{
    "id": "dbpedia_6045_0",
    "rank": 72,
    "data": {
        "url": "https://www.business-standard.com/article/international/covid-china-delivers-500-000-doses-of-sinopharm-vaccine-to-bangladesh-121051200545_1.html",
        "read_more_link": "",
        "language": "en",
        "title": "Covid: China delivers 500,000 doses of Sinopharm vaccine to Bangladesh",
        "top_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/07/full/1620401370-606.jpg",
        "meta_img": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/07/full/1620401370-606.jpg",
        "images": [
            "https://sb.scorecardresearch.com/p?c1=2&c2=8021726&cv=4.4.0&cj=1",
            "https://bsmedia.business-standard.com/include/_mod/site/html5/images/business-standard-logo.png",
            "https://www.business-standard.com/assets/web-assets/images/logo-bs.webp",
            "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/07/full/1620401370-606.jpg?im=FeatureCrop,size=(826,465)",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/images/Business_Standard_328x185.jpg",
            "https://www.business-standard.com/assets/web-assets/icons/LinkedIN.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Companies of China",
            "COVID-19 vaccines",
            "China National Pharmaceutical Group",
            "Drugs",
            "Clinical trials",
            "Companies",
            "BBIBP-CorV",
            "Medical research",
            "Sinopharm Group",
            "Biotechnology & Medical Research (NEC)",
            "Pharmaceuticals (NEC)",
            "SERUM INSTITUTE OF INDIA",
            "Li Jiming",
            "China",
            "World Health Organization",
            "Bangladesh",
            "Ambassador to Bangladesh Li Jiming",
            "Russia",
            "AstraZeneca",
            "United States",
            "India",
            "Serum Institute of India",
            "infections",
            "Dhaka",
            "Oxford",
            "Sinopharm"
        ],
        "tags": null,
        "authors": [
            "Business Standard"
        ],
        "publish_date": "2021-05-12T13:56:00+05:30",
        "summary": "",
        "meta_description": "China delivered 500,000 doses of Sinopharm vaccine as a gift to Bangladesh on Wednesday to help it cope with a shortage.\nBangladesh, a nation of 160 million people, is in desperate need after India banned exports of Oxford-AstraZeneca vaccines produced by the Serum Institute of India because of its own devastating surge in infections.\nChinese Ambassador to Bangladesh Li Jiming formally handed over the Sinopharm vaccines in Dhaka on Wednesday. Bangladesh has already approved the Chinese vaccines after the World Health Organization has recently listed the Sinopharm for emergency use globally.\nBangladesh received about 7 million doses from the Indian institute, but its deal had called for 30 million doses to be delivered by June.\nBangladesh already suspended administering the first dose of vaccines. Some few hundreds of thousands of people are due their second dose but would be left out if new doses do not arrive soon.\nBangladesh has attempted to diversify its vaccine sources, asking the",
        "meta_lang": "en",
        "meta_favicon": "https://www.business-standard.com/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.business-standard.com/article/international/covid-china-delivers-500-000-doses-of-sinopharm-vaccine-to-bangladesh-121051200545_1.html",
        "text": "(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)"
    }
}